Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Novartis
Pharmaceuticals
Sanofi
Novo Nordisk
Pfizer
AstraZeneca
GSK
Johnson & Johnson
AbbVie
Topics

Advertisement

Novartis

Share

Top Latest Popular

In the last 4 hours

“Voice for Her Power” Unites Sectors to Advance Equity in Breast Cancer Care Bangkok Post 03:56

Yesterday

Genentech, Novartis Accused of Drug Kickback Schemes in Lawsuit Bloomberg Law 15:36 Mon, 22 Jun

BioArctic and Lilly sign $30m collaboration combining BrainTransporter with Lilly neurodegeneration asset Manufacturing Chemist 10:25 Mon, 22 Jun

Advertisement

Advertisement

Friday

ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain Pharmaceutical Technology 09:56 Fri, 19 Jun

Thursday

Patent Claims On Novartis Unit Drug Invalid, Del. Judge Says Law360 20:28 Thu, 18 Jun

Curium Knocks Out Novartis Cancer Drug Patents in Generics Fight Bloomberg Law 01:39 Thu, 18 Jun

In the last month

Novartis' Rhapsido Meets Primary Goal in Phase III Skin Disorder Study Zacks 16:38 Mon, 15 Jun

Novartis brings in its advanced-prostrate-cancer drug to India The Hindu Business Line 11:33 Mon, 15 Jun

Novartis India launches Pluvicto for prostate cancer treatment The Economic Times 10:49 Mon, 15 Jun

Novartis' Rhapsido Shows Promise In Chronic Inducible Urticaria RTT News 13:31 Fri, 12 Jun

Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU) Novartis (Press Release) 11:43 Fri, 12 Jun

India needs to remain attractive for innovation-led investment: Judith Love, Novartis The Times of India 20:11 Thu, 11 Jun

ASCO: Novartis To Face Challengers In Growing Radiopharmaceutical Space Scrip Pharma Intelligence 19:35 Thu, 11 Jun

Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines Zacks 19:25 Thu, 11 Jun

Novartis Reports Positive Data for Neuromuscular Disorder Drug Zacks 19:25 Thu, 11 Jun

Market Outlook: Apple, Novartis, Rio Tinto stand out on momentum trends BNN Bloomberg 16:55 Thu, 11 Jun

Advertisement

Novartis $12bn bet on Avidity well placed after mid-stage FSHD win Clinical Trials Arena 16:21 Thu, 11 Jun

STAT Plus: Novartis doubles down on molecular glue strategy STAT 15:13 Thu, 11 Jun

Positive Del-Brax Biomarker Data Offers Early Support For Novartis’s Avidity Bet Scrip Pharma Intelligence 14:19 Thu, 11 Jun

Orionis Back In Novartis’s Orbit With New Molecular Glue Deal Scrip Pharma Intelligence 14:09 Thu, 11 Jun

Novartis gets win for another Avidity muscular dystrophy AOC pharmaphorum 13:14 Thu, 11 Jun

Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint Novartis (Press Release) 07:04 Thu, 11 Jun

Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis BioWorld 21:48 Wed, 10 Jun

Genentech and Novartis dish up food allergy microdrama series FiercePharma 19:12 Wed, 10 Jun

Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines Business Wire (Press Release) 12:03 Wed, 10 Jun

Novartis, AbbVie Lose Bid To Halt Wash. 340B Pharmacy Law Law360 04:04 Wed, 10 Jun

ASCO: Novartis To Face Challenges In Growing Radiopharmaceutical Space Scrip Pharma Intelligence 23:18 Tue, 09 Jun

Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026 Novartis (Press Release) 08:53 Mon, 08 Jun

Novartis reports positive results from Phase III ALIGN trial for IgAN Clinical Trials Arena 10:44 Fri, 05 Jun

EULAR: Novartis Closes In On Final Approval For Cosentyx Scrip Pharma Intelligence 08:23 Fri, 05 Jun

Novartis Vanrafia Data Show Clinically Meaningful Kidney Protection In IgA Nephropathy RTT News 12:51 Thu, 04 Jun

Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years Novartis (Press Release) 11:29 Thu, 04 Jun

Novartis Cosentyx Shows Sustained Remission In Polymyalgia Rheumatica RTT News 10:49 Thu, 04 Jun

Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients Novartis (Press Release) 16:38 Wed, 03 Jun

Accelerating Structure Verification Across Novartis Drugs Discovery Online 19:37 Tue, 02 Jun

ASCO 2026: Mixed SCLC result for Legend’s LB2102, Novartis expedites manufacture Pharmaceutical Technology 17:13 Tue, 02 Jun

Novartis Pluvicto And Actinium Program Advance Radioligand Therapy In Prostate Cancer RTT News 09:46 Mon, 01 Jun

Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases Novartis (Press Release) 06:30 Mon, 01 Jun

Experimental Novartis radiopharma drug shows promise in early study The Tribune, California 12:48 Sun, 31 May

Novartis experimental actinium-based drug shows promise in prostate cancer treatment: Study The Times of India 12:40 Sun, 31 May

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis